Skip to main content
SpringerLink
Log in

A Low Molecular Weight Agonist of the Luteinizing Hormone Receptor Stimulates Adenylyl Cyclase in the Testicular Membranes and Steroidogenesis in the Testes of Rats with Type 1 Diabetes

  • Published:
Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology Aims and scope

Abstract—

A characteristic feature of type 1 diabetes mellitus (DM1) in humans and experimental animals is an androgen deficiency, which is usually compensated by using the gonadotropin preparations with the activity of the agonists of the luteinizing hormone (LH) receptor, including human chorionic gonadotropin (hCG). However, the use of gonadotropins is associated with a number of undesirable effects, and their steroidogenic effect is weakened at the conditions of DM1. An alternative to gonadotropins can be low molecular weight thienopyrimidine-based agonists of the LH/hCG receptor, which bind to an allosteric site located within the transmembrane channel of this receptor. In this study the stimulating effect of hCG and the thienopyrimidine derivative TP03 we have developed earlier on the adenylyl cyclase (AC) in the testicular membranes of male rats with moderate/severe streptozotocin DM1 have been investigated along with the effects of hCG and TP03 on the plasma testosterone levels and the gene expression of steroidogenic proteins in the testes of diabetic rats under a single or 5-day administration of these drugs. In DM1, the AC-stimulating effects of hCG, TP03, and guanine nucleotides were decreased in the testicular membranes, and the EC50 of the effects of hCG and TP03 were increased; this indicated a reduced sensitivity of the LH/hCG receptors to hCG and TP03 in DM1 and could be associated with a decrease in functional activity of heterotrimeric G proteins. In diabetic rats with reduced basal testosterone levels, the steroidogenic effects of the single-dose hCG and TP03 were significantly reduced; and the effect of hCG was significantly higher than that of TP03. In the case of a 5-day treatment of diabetic rats with hCG and TP03, only the steroidogenic effect of gonadotropin was reduced, while the corresponding effect of TP03 did not change and was comparable to the effect of hCG. The regulatory effects of TP03 on the expression of steroidogenic proteins in the testes of control and diabetic rats were similar under the 5-day administration. The TP03 compound, in contrast to hCG, in the control and diabetic groups, did not reduce the expression of the Lhr gene, which encodes LH/hCG receptor, thereby preventing a decrease in the sensitivity of the testes to gonadotropins in DM1. Thus, a low molecular weight agonist TP03 is an effective stimulator of testosterone synthesis in severe DM1 with androgen deficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.

Similar content being viewed by others

REFERENCES

  1. Schoeller E.L., Schon S., Moley K.H. 2012. The effects of type 1 diabetes on the hypothalamic, pituitary and testes axis. Cell Tissue Res.349 (3), 839–847.

    Article  CAS  Google Scholar 

  2. Jangir R.N., Jain G.C. 2014. Diabetes mellitus induced impairment of male reproductive functions: A review. Curr. Diabetes Rev.10 (3), 147–157.

    Article  CAS  Google Scholar 

  3. Shpakov A.O. 2018. Gonadotropiny – ot teorii k klinicheskoy praktike (Gonadotropins – From theory to clinical practice). St.-Petersburg: Polytech-press.

  4. Shpakov A. O. 2010. The functional state of the hypothalamic-pituitary-gonad system in diabetes mellitus. Problemy Endokrinologii (Rus.). 56 (5), 23–29.

    Article  CAS  Google Scholar 

  5. Carruthers M. 2013. Testosterone deficiency syndrome: Cellular and molecular mechanism of action. Curr. Aging Sci.6 (1), 115–124.

    Article  CAS  Google Scholar 

  6. Liu H., Lin S., Lv Q., Yang Q., Wu G., Hu J., Yang J. 2017. Taurine recovers testicular steroidogenesis and spermatogenesis in streptozotocin-induced diabetic rats. Adv. Exp. Med. Biol.975 (Pt 2), 801–811.

    Article  CAS  Google Scholar 

  7. van Koppen C.J., Zaman G.J., Timmers C.M., Kelder J., Mosselman S., van de Lagemaat R., Smit M.J., Hanssen R.G. 2008. A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor. Naunyn Schmiedebergs Arch. Pharmacol.378 (5), 503–514.

    Article  CAS  Google Scholar 

  8. Newton C.L., Whay A.M., McArdle C.A., Zhang M., van Koppen C.J., van de Lagemaat R., Segaloff D.L., Millar R.P. 2011. Rescue of expression and signaling of human luteinizing hormone G protein-coupled receptor mutants with an allosterically binding small-molecule agonist. Proc. Natl. Acad. Sci. USA.108 (17), 7172–7176.

    Article  CAS  Google Scholar 

  9. van de Lagemaat R., Raafs B.C., van Koppen C., Timmers C.M., Mulders S.M., Hanssen R.G. 2011. Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH. Endocrinology.152 (11), 4350–4357.

    Article  CAS  Google Scholar 

  10. Nataraja S.G., Yu H.N., Palmer S.S. 2015. Discovery and development of small molecule allosteric modulators of glycoprotein hormone receptors. Front Endocrinol (Lausanne).6, 142. https://doi.org/10.3389/fendo.2015.00142

    Article  Google Scholar 

  11. Derkach K.V., Dar’in D.V., Bakhtyukov A.A., Lobanov P.S., Shpakov A.O. 2016. In vitro and in vivo studies of functional activity of new low molecular weight agonists of the luteinizing hormone receptor. Biochem. (Moscow)Suppl. Series A.10 (4), 294–300.

    Google Scholar 

  12. Bakhtyukov A.A., Sokolova T.V., Dar’in D.V., Derkach K.V., Shpakov A.O. 2017. Comparative study of the stimulating effect of a low molecular weight agonist of the luteinizing hormone receptor and chorionic gonadotropin on steroidogenesis in rat Leydig cells. Rossiyskiy fiziologich. zhurnal (Rus.). 103 (10), 1181–1192.

  13. Derkach K.V., Bakhtyukov A.A., Shpakov A.A., Dar’in D.V., Shpakov A.O. 2017. Specificity of heterotrimeric G protein regulation by human chorionic gonadotropin and low-molecular agonist of luteinizing hormone receptor. Cell Tissue Biol.11 (6), 475–482.

    Article  Google Scholar 

  14. Shpakov A.O., Derkach K.V., Dar’in D.V., Lobanov P.S. 2014. Activation of adenylyl cyclase by thienopyrimidine derivatives in rat testes and ovaries. Cell Tissue Biol.8 (5), 400–406.

    Article  Google Scholar 

  15. Derkach K.V., Bondareva V.M., Chistyakova O.V., Berstein L.M., Shpakov A.O. 2015. The effect of long-term intranasal serotonin treatment on metabolic parameters and hormonal signaling in rats with high-fat diet/low-dose streptozotocin-induced type 2 diabetes. Int. J. Endocrinol.2015, 245459.

    Article  Google Scholar 

  16. Cicognani A., Zappulla F., Bernardi F., Capelli M., Mazzanti L., Turchi S., Radetti G., Pirazzoli P., Cacciari E. 1978. Hypophyso-gonadal function in the diabetic child. Acta Paediatr Scand.67 (2), 151–155.

    Article  CAS  Google Scholar 

  17. Mikhailichenko V.V., Tiktinskii O.L., Sil’nitskii P.A., Vorokhobina N.V., Aleksandrov V.P. 1993. The pathogenesis of sexual disorders in men with diabetes mellitus. Urol. Nefrol. (Mosk). (Rus.). 2, 47–50.

    Google Scholar 

  18. Shpakov A.O., Derkach K.V., Bondareva V.M. 2009. Changes in hormone sensitivity of the adenylate cyclase signaling system in the testicular tissue of rats with neonatal streptozotocin-induced diabetes. Bull. Exp. Biol. Med.148 (3), 394–398.

    Article  CAS  Google Scholar 

  19. Bakhtyukov A.A., Derkach K.V., Shpakov A.O. 2019. The relationship between androgen deficiency and the weakening of the sensitivity of adenylyl cyclase to gonadotropins in the testes of rats with streptozotocin diabetes of varying severity. Rossiyskiy fiziologich. zhurnal (Rus.). 105 (1), 100–110.

  20. Casarini L., Lispi M., Longobardi S., Milosa F., La Marca A., Tagliasacchi D., Pignatti E., Simoni M. 2012. LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signaling. PLoS One.7, e46682. https://doi.org/10.1371/journal.pone.0046682

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Riccetti L., De Pascali F., Gilioli L., Potì F., Giva L.B., Marino M., Tagliavini S., Trenti T., Fanelli F., Mezzullo M., Pagotto U., Simoni M., Casarini L. 2017. Human LH and hCG stimulate differently the early signalling pathways but result in equal testosterone synthesis in mouse Leydig cells in vitro. Reprod. Biol. Endocrinol.15 (1), 2.

    Article  Google Scholar 

  22. Zhao Y.T., Qi Y.W., Hu C.Y., Chen S.H., Liu Y. 2016. Advanced glycation end products inhibit testosterone secretion by rat Leydig cells by inducing oxidative stress and endoplasmic reticulum stress. Int. J. Mol. Med.38 (2), 659–665.

    Article  CAS  Google Scholar 

  23. Tanaka M., Nakaya S., Kumai T., Watanabe M., Matsumoto N., Kobayashi S. 2001. Impaired testicular function in rats with diet-induced hypercholesterolemia and/or streptozotocin-induced diabetes mellitus. Endocr. Res.27 (1–2), 109–117.

    Article  CAS  Google Scholar 

  24. Dedov I.I., Melnichenko G.A., Shestakova M.V., Rozhivanov L.V., Terekhova A.L., Zilov A.V., Ladygina D.O., Kurbatov D.G. 2017. Recommendations for the diagnosis and treatment of testosterone deficiency (hypogonadism) in men with diabetes. Ozhirenie i metabolizm (Rus.). 14 (4), 83–92.

  25. Shpakov A.O., Ryzhov Ju.R., Bakhtyukov A.A., Derkach K.V. 2018. The regulation of the male hypothalamic-pituitary-gonadal axis and testosterone production by adipokines. Adv. Testosterone Action. Ed. M. Estrada. Rijeka, Croatia: Intech. Open Access Publ. P. 25–57. https://doi.org/10.5772/intechopen.76321

    Google Scholar 

Download references

ACKNOWLEDGMENTS

The work was supported by the Russian Science Foundation (project no. 19-75-20122).

Author information

Authors and Affiliations

  1. Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 194223, St. Petersburg, Russia

    A. A. Bakhtyukov, K. V. Derkach, A. M. Stepochkina & A. O. Shpakov

  2. St.-Petersburg State University, 199034, St. Petersburg, Russia

    D. V. Dar’in

Authors
  1. A. A. Bakhtyukov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. V. Derkach
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. V. Dar’in
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. M. Stepochkina
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. O. Shpakov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. O. Shpakov.

Ethics declarations

Conflict of interests. The authors declare that they have no conflict of interest.

Statement on the welfare of animals. All experiments were performed in accordance with the requirements of the bioethics Committee of IEPhB RAS and European Communities Council Directive 1986 (86/609/EEC).

Additional information

Translated by E. Puchkov

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bakhtyukov, A.A., Derkach, K.V., Dar’in, D.V. et al. A Low Molecular Weight Agonist of the Luteinizing Hormone Receptor Stimulates Adenylyl Cyclase in the Testicular Membranes and Steroidogenesis in the Testes of Rats with Type 1 Diabetes. Biochem. Moscow Suppl. Ser. A 13, 301–309 (2019). https://doi.org/10.1134/S1990747819040032

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1990747819040032

Keywords:

Search

Navigation